Alterity Therapeutics Ltd (ATHE)
2.20
+0.10
(+5.01%)
USD |
NASDAQ |
May 01, 16:00
2.22
+0.02
(+0.91%)
After-Hours: 20:00
Alterity Therapeutics Total Return Level: 2.095 for April 30, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 30, 2024 | 2.095 |
April 29, 2024 | 2.195 |
April 26, 2024 | 2.51 |
April 25, 2024 | 2.26 |
April 24, 2024 | 2.33 |
April 23, 2024 | 2.13 |
April 22, 2024 | 2.13 |
April 19, 2024 | 2.04 |
April 18, 2024 | 2.14 |
April 17, 2024 | 2.01 |
April 16, 2024 | 2.05 |
April 15, 2024 | 2.45 |
April 12, 2024 | 2.94 |
April 11, 2024 | 2.63 |
April 10, 2024 | 2.19 |
April 09, 2024 | 1.91 |
April 08, 2024 | 1.88 |
April 05, 2024 | 1.88 |
April 04, 2024 | 1.835 |
April 03, 2024 | 1.84 |
April 02, 2024 | 1.83 |
April 01, 2024 | 1.95 |
March 28, 2024 | 2.07 |
March 27, 2024 | 2.02 |
March 26, 2024 | 1.80 |
Date | Value |
---|---|
March 25, 2024 | 1.71 |
March 22, 2024 | 1.77 |
March 21, 2024 | 1.77 |
March 20, 2024 | 1.71 |
March 19, 2024 | 1.67 |
March 18, 2024 | 1.80 |
March 15, 2024 | 1.76 |
March 14, 2024 | 1.80 |
March 13, 2024 | 1.87 |
March 12, 2024 | 1.66 |
March 11, 2024 | 1.71 |
March 08, 2024 | 1.705 |
March 07, 2024 | 1.66 |
March 06, 2024 | 1.71 |
March 05, 2024 | 1.75 |
March 04, 2024 | 1.73 |
March 01, 2024 | 1.73 |
February 29, 2024 | 1.87 |
February 28, 2024 | 1.905 |
February 27, 2024 | 1.90 |
February 26, 2024 | 1.84 |
February 23, 2024 | 1.71 |
February 22, 2024 | 2.04 |
February 21, 2024 | 2.04 |
February 20, 2024 | 2.03 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.66
Minimum
Nov 22 2023
34.30
Maximum
Aug 04 2020
8.766
Average
7.70
Median
Jan 02 2020
Total Return Level Benchmarks
Kazia Therapeutics Ltd | 0.3348 |
Immutep Ltd | 2.67 |
Opthea Ltd | 3.40 |
Mesoblast Ltd | 6.60 |
Immuron Ltd | 2.22 |